Market brief — September 29, 2026

Yesterday, the market closed with a clear rates shock still in control: the CAC 40 finished at 8,078.48 (+0.01%), the S&P 500 at 7,683.69 (-0.77%), the Nasdaq at 26,820.38 (-0.92%), the DAX at 25,374.42 (-0.13%), and the Euro Stoxx 50 at 6,301.28 (-0.02%). The move was not clean risk-off so much as a repricing of the discount-rate complex, with Reuters reporting that the 10-year U.S. Treasury yield pushed above 5.20% and briefly to 5.27% overnight, while the 30-year approached 5.56% and the 2-year moved toward 5% as oil-driven inflation fears and renewed Fed-hike bets dominated sentiment.^[1][2][3]

That matters because the dominant narrative is no longer “equities can ignore yields”; it is “equities are trading under a higher-for-longer rate regime that is tightening financial conditions in real time.” The cross-asset setup confirms that: the dollar is firm near a two-month high, gold is soft, and bond volatility is elevated, which is consistent with systematic de-risking rather than purely discretionary stock picking.^[1][3][5] The key divergence is that European indices held up better than U.S. growth proxies, which suggests the market is still discriminating between rate-sensitive duration trades and more insulated cash-generative defensives. That keeps the next few sessions vulnerable to another leg lower in high-duration assets if Treasury yields fail to stabilize.

Today’s Cash Scanner fits that same regime rather than contradicting it. The strongest cluster is in life sciences tools and healthcare: Thermo Fisher Scientific Inc. (score 39, +0.5%, U.S. life sciences tools, ADX 42, vortex↑), Danaher Corp. (score 38, +1.3%, U.S. life sciences tools, breakout 20d, volume↑), PACIFIC BIOSCIENCES OF CALIFORNIA INC PACB (score 38, +5.6%, U.S. life sciences tools, breakout 20d, volume↑), and Agilent Technologies Inc. (score 36, +1.4%, U.S. life sciences tools, breakout 20d, volume↑). That is a defensive growth pocket with technical confirmation, not a broad risk-on tape. The more speculative names, Stellar (score 40, +7.7%, breakout 20d, volume↑) and Chainlink (score 38, +10.2%, breakout 20d, volume↑), show momentum in crypto-related risk, but they look idiosyncratic rather than a full regime shift. Twilio-A (score 37, +4.1%, U.S. technology, vortex↑, volume↑) and Banco Com Port (score 36, +1.8%, Portugal banking, breakout 20d, volume↑) reinforce selective rotation, while ALLEGRO.EU PLN (score 40, +0.6%, retail/consumer, ADX 30, KST↑) points to a few European consumer names catching trend-following interest.

Over the next 1–5 sessions, the dominant trade is likely to remain the bond-market repricing itself rather than any single earnings story. Consensus still appears to expect yields to consolidate after the September surge, but the recent move suggests the market has not yet priced the full impact of energy-driven inflation persistence and the risk of an even more hawkish Fed path. A contrarian scenario is that yields stall if U.S. data soften and the dollar peaks, which would let crowded duration shorts unwind quickly; that would help the Nasdaq and high-multiple healthcare names most.

The most important catalysts are the next U.S. inflation-sensitive data releases and Fed communication, the Australian central bank decision later today, and any further escalation in oil-linked geopolitical risk that would keep the inflation impulse alive. Treasury supply is also a near-term risk because a weak auction could extend the selloff and force another round of equity de-risking.^{[1][2][3][14]}

What to watch: if the U.S. 10-year stays above roughly 5.20% and the 2-year holds near 5%, the current defensive rotation should persist and the scanner’s healthcare/life-sciences strength should remain bid; if yields ease back under those levels, the recent breakout names in Twilio-A, Danaher Corp., and Agilent Technologies Inc. are the first to benefit. If the dollar index keeps firming and oil remains elevated, the Nasdaq’s underperformance versus the CAC 40 and Euro Stoxx 50 should continue; if crude rolls over and bond volatility compresses, that divergence should narrow quickly. If Bitcoin-linked momentum in Stellar and Chainlink fades while volume stays elevated, it would signal that speculative risk appetite is narrowing again rather than broadening out.

Bonne journée aux p&l makers.